{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:21Z","timestamp":1752105621272,"version":"3.41.2"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>This computational study evaluates the accuracy of kinetic models and acquisition schemes in dynamic PET imaging using simulations of <jats:sup>18<\/jats:sup>F-fallypride PET in the human brain on the real-world data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We employed a 2-tissue 4-k model to generate ideal tissue curves for three regions (putamen, thalamus, and temporal cortex) and a reference region (cerebellum), incorporating a simulated metabolite-corrected input function. Realistic measurements were simulated over a 240-min PET scan by defining acquisition protocols (frame timings and durations), modeling tracer decay, and adding noise. Distribution volume ratios (DVRs) were calculated using the Logan reference analysis and the simplified reference tissue model (SRTM), the relative error in DVR was also assessed across various acquisition protocols. Rate constants from the 2-tissue model were varied, and Bland\u2013Altman analysis was quantified to determine bias relative to ground-truth DVR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Results indicate that, under low noise conditions, the Logan reference method performed optimally with a protocol involving a 60-min dynamic scan, a 60-min break, a 30-min scan, another 60-min break, and a final 30-min scan. In noisier conditions, the SRTM yielded the best results with a 150-min effective scan time incorporating three breaks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These findings highlight the impact of noise and acquisition strategy on model performance, informing optimal PET imaging protocols.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001995","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:00:11Z","timestamp":1749182411000},"page":"760-771","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The use of simulations to study the effect of acquisition schemes and quantification methods using positron emission tomography: an 18F-Fallypride study"],"prefix":"10.1097","volume":"46","author":[{"given":"Mohlapoli S.","family":"Mohlapholi","sequence":"first","affiliation":[{"name":"Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University"},{"name":"Medical Physics, Stellenbosch University and Tygerberg Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Doruyter","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University"},{"name":"NuMeRI Node for Infection Imaging, Central Analytical Facilities, Stellenbosch University, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mix","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University"},{"name":"Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Trauernicht","sequence":"additional","affiliation":[{"name":"Medical Physics, Stellenbosch University and Tygerberg Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annare","family":"Ellmann","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Warwick","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Dupont","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University"},{"name":"Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"R1-20250709","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2967\/jnumed.117.200964","article-title":"Validation of noninvasive tracer kinetic analysis of 18F-florbetaben PET using a dual\u2013time-window acquisition protocol.","volume":"59","author":"Bullich","year":"2018","journal-title":"J Nucl Med"},{"key":"R2-20250709","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13550-019-0499-4","article-title":"Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies.","volume":"9","author":"Heeman","year":"2019","journal-title":"EJNMMI Res"},{"key":"R3-20250709","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11307-021-01581-5","article-title":"Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies.","volume":"23","author":"Tuncel","year":"2021","journal-title":"Mol Imaging Biol"},{"key":"R4-20250709","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","article-title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review.","volume":"49","author":"Pemberton","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20250709","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies.","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"R6-20250709","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","article-title":"Comparison of methods for analysis of clinical [11C]raclopride studies.","volume":"16","author":"Lammertsma","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"R7-20250709","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data.","volume":"16","author":"Logan","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"R8-20250709","first-page":"964","article-title":"Parametric mapping of binding in human brain of D2 receptor ligands of different affinities.","volume":"46","author":"Siessmeier","year":"2005","journal-title":"J Nucl Med"},{"key":"R9-20250709","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","article-title":"Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.","volume":"50","author":"Nelissen","year":"2009","journal-title":"J Nucl Med"},{"key":"R10-20250709","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.npp.1300916","article-title":"Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.","volume":"31","author":"Riccardi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R11-20250709","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1523\/JNEUROSCI.2423-08.2008","article-title":"Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans.","volume":"28","author":"Zald","year":"2008","journal-title":"J Neurosci"},{"key":"R12-20250709","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2967\/jnumed.111.099416","article-title":"Optimized in vivo detection of dopamine release using 18F-fallypride PET.","volume":"53","author":"Ceccarini","year":"2012","journal-title":"J Nucl Med"},{"key":"R13-20250709","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/syn.21630","article-title":"Surrogate markers for cerebral blood flow correlate with [18F]-fallypride binding potential at dopamine D2\/3 receptors in human striatum.","volume":"67","author":"Cumming","year":"2013","journal-title":"Synapse"},{"key":"R14-20250709","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2017.03.013","article-title":"[18F]-fallypride PET-CT of dopamine D2\/D3 receptors in patients with sporadic amyotrophic lateral sclerosis.","volume":"377","author":"Fu","year":"2017","journal-title":"J Neurol Sci"},{"key":"R15-20250709","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1523\/JNEUROSCI.3082-17.2018","article-title":"Nigrostriatal and mesolimbic d(2\/3) receptor expression in parkinson\u2019s disease patients with compulsive reward-driven behaviors.","volume":"38","author":"Stark","year":"2018","journal-title":"J Neurosci"},{"key":"R16-20250709","doi-asserted-by":"crossref","first-page":"e22064","DOI":"10.1002\/syn.22064","article-title":"Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [18F]fallypride PET and functional MRI study.","volume":"72","author":"Kim","year":"2018","journal-title":"Synapse"},{"key":"R17-20250709","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1017\/S003329171900062X","article-title":"Lower [18F]fallypride binding to dopamine D2\/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study.","volume":"50","author":"van Duin","year":"2019","journal-title":"Psychol Med"},{"key":"R18-20250709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2013.00065","article-title":"The simplified reference tissue model with 18F-Fallypride positron emission tomography: choice of reference region.","volume":"12","author":"Ishibashi","year":"2013","journal-title":"Mol Imaging"},{"key":"R19-20250709","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/jcbfm.2014.202","article-title":"The simplified reference tissue model: model assumption violations and their impact on binding potential.","volume":"35","author":"Salinas","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"R20-20250709","first-page":"464","article-title":"Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.","volume":"45","author":"Honer","year":"2004","journal-title":"J Nucl Med"},{"key":"R21-20250709","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.nucmedbio.2009.06.007","article-title":"[18F]-fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.","volume":"36","author":"Tantawy","year":"2009","journal-title":"Nucl Med Biol"},{"key":"R22-20250709","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/syn.20904","article-title":"Striatal and extrastriatal microPET imaging of D2\/D3 dopamine receptors in rat brain with [18F]fallypride and [18F]desmethoxyfallypride.","volume":"65","author":"Constantinescu","year":"2011","journal-title":"Synapse"},{"key":"R23-20250709","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/jcbfm.2011.73","article-title":"The applicability of SRTM in [18F]fallypride PET investigations: impact of scan durations.","volume":"31","author":"Vernaleken","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"R24-20250709","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/jcbfm.2013.55","article-title":"Establishing test-retest reliability of an adapted [18F]fallypride imaging protocol in older people.","volume":"33","author":"Dunn","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"R25-20250709","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/syn.10128","article-title":"Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2\/D-3 receptors.","volume":"46","author":"Mukherjee","year":"2002","journal-title":"Synapse"},{"key":"R26-20250709","first-page":"924","article-title":"A fast nonlinear method for parametric imaging of myocardial perfusion by dynamic 13N-ammonia PET.","volume":"42","author":"Golish","year":"2001","journal-title":"J Nucl Med"},{"key":"R27-20250709","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1088\/0031-9155\/37\/7\/010","article-title":"A simplified formulation of the gamma variate function.","volume":"37","author":"Madsen","year":"1992","journal-title":"Phys Med Biol"},{"key":"R28-20250709","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.WCB.0000105020.93708.DD","article-title":"Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.","volume":"24","author":"Christian","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"R29-20250709","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-004-1830-x","article-title":"In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.","volume":"175","author":"Slifstein","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"R30-20250709","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroimage.2005.11.052","article-title":"Measuring dopamine neuromodulation in the thalamus: Using [18F]fallypride PET to study dopamine release during a spatial attention task.","volume":"31","author":"Christian","year":"2006","journal-title":"Neuroimage"},{"key":"R31-20250709","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1528-1167.2006.00561.x","article-title":"Decreased dopamine D2\/D3-receptor binding in temporal lobe epilepsy: An [18F]-fallypride PET study.","volume":"47","author":"Werhahn","year":"2006","journal-title":"Epilepsia"},{"key":"R32-20250709","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/jcbfm.2009.270","article-title":"High-affinity dopamine D2\/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.","volume":"30","author":"Vandehey","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"R33-20250709","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.jcbfm.9600359","article-title":"Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics.","volume":"27","author":"Morris","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"R34-20250709","first-page":"978","article-title":"Kinetic modelling in human brain imaging.","author":"Nelissen","year":"2012","journal-title":"PET-Curr Clin Res Aspec"},{"key":"R35-20250709","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004647-200103000-00014","article-title":"A strategy for removing the bias in the graphical analysis method.","volume":"21","author":"Logan","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"R36-20250709","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.nicl.2018.02.010","article-title":"[18F]fallypride characterization of striatal and extrastriatal D(2\/3) receptors in Parkinson\u2019s disease.","volume":"18","author":"Stark","year":"2018","journal-title":"Neuroimage Clin"},{"key":"R37-20250709","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0271678X17737693","article-title":"Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences.","volume":"39","author":"Smith","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"R38-20250709","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nicl.2016.06.007","article-title":"Occupancy of pramipexole (Sifrol) at cerebral dopamine D2\/3 receptors in Parkinson\u2019s disease patients.","volume":"12","author":"Deutschl\u00e4nder","year":"2016","journal-title":"Neuroimage Clin"},{"key":"R39-20250709","doi-asserted-by":"crossref","first-page":"e0191299","DOI":"10.1371\/journal.pone.0191299","article-title":"Brief exposure to obesogenic diet disrupts brain dopamine networks.","volume":"13","author":"Barry","year":"2018","journal-title":"PLoS One"},{"key":"R40-20250709","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(89)90179-6","article-title":"Dopamine receptors in human brain: autoradiographic distribution of D2 sites.","volume":"28","author":"Camps","year":"1989","journal-title":"Neuroscience"},{"key":"R41-20250709","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement.","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R42-20250709","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1017\/S1461145710000374","article-title":"Dopamine D2\/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.","volume":"13","author":"Vernaleken","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R43-20250709","first-page":"2083","article-title":"Effects of statistical noise on graphic analysis of PET neuroreceptor studies.","volume":"41","author":"Slifstein","year":"2000","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:01:03Z","timestamp":1752062463000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001995","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"type":"print","value":"0143-3636"},{"type":"electronic","value":"1473-5628"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}